Search research articles
Contact Us
Filters
Showing results (111-120 of 162) with videos related to
Page
of 17
Sort By:
Sleep Medicine
|
July 11, 2021
Assessing the impact of sodium oxybate treatment on functioning, productivity, and health-related quality of life in patients with narcolepsy: findings from the Nexus Narcolepsy Registry (waves 1-4)
Michael J Thorpy, Maurice M Ohayon, Ginger Carls, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
May 8, 2012
Risk factors for rate of decline in FEV1 in adults with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Donald R Vandevanter, et al.
Pediatric Pulmonology
|
August 19, 2010
Trends in the use of routine therapies in cystic fibrosis: 1995-2005
Michael W Konstan, Donald R VanDevanter, Lawrence Rasouliyan, et al.
Urology
|
June 9, 2004
Obstructive lower urinary tract symptoms correlate with erectile dysfunction
Sean P Elliott, Mittul Gulati, David J Pasta, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2004
Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE
Joycelyn L Speight, Eric P Elkin, David J Pasta, et al.
Pediatric Pulmonology
|
October 11, 2008
The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis
Gregory S Sawicki, Lawrence Rasouliyan, David J Pasta, et al.
Pediatric Pulmonology
|
June 19, 2015
Decline in lung function does not predict future decline in lung function in cystic fibrosis patients
Margaret Rosenfeld, Donald R VanDevanter, Clement L Ren, et al.
Pediatric Pulmonology
|
August 14, 2012
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis
Jeffrey S Wagener, Lawrence Rasouliyan, Donald R VanDevanter, et al.
Pediatric Pulmonology
|
August 19, 2010
Pulmonary outcome prediction (POP) tools for cystic fibrosis patients
Donald R VanDevanter, Jeffrey S Wagener, David J Pasta, et al.
Pediatric Pulmonology
|
September 18, 2010
Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis
Gregory S Sawicki, Lawrence Rasouliyan, Ann H McMullen, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 162) with videos related to
Sort By:
Page
of 17
Sleep Medicine
|
July 11, 2021
Assessing the impact of sodium oxybate treatment on functioning, productivity, and health-related quality of life in patients with narcolepsy: findings from the Nexus Narcolepsy Registry (waves 1-4)
Michael J Thorpy, Maurice M Ohayon, Ginger Carls, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
May 8, 2012
Risk factors for rate of decline in FEV1 in adults with cystic fibrosis
Michael W Konstan, Jeffrey S Wagener, Donald R Vandevanter, et al.
Pediatric Pulmonology
|
August 19, 2010
Trends in the use of routine therapies in cystic fibrosis: 1995-2005
Michael W Konstan, Donald R VanDevanter, Lawrence Rasouliyan, et al.
Urology
|
June 9, 2004
Obstructive lower urinary tract symptoms correlate with erectile dysfunction
Sean P Elliott, Mittul Gulati, David J Pasta, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2004
Longitudinal assessment of changes in sexual function and bother in patients treated with external beam radiotherapy or brachytherapy, with and without neoadjuvant androgen ablation: data from CaPSURE
Joycelyn L Speight, Eric P Elkin, David J Pasta, et al.
Pediatric Pulmonology
|
October 11, 2008
The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis
Gregory S Sawicki, Lawrence Rasouliyan, David J Pasta, et al.
Pediatric Pulmonology
|
June 19, 2015
Decline in lung function does not predict future decline in lung function in cystic fibrosis patients
Margaret Rosenfeld, Donald R VanDevanter, Clement L Ren, et al.
Pediatric Pulmonology
|
August 14, 2012
Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis
Jeffrey S Wagener, Lawrence Rasouliyan, Donald R VanDevanter, et al.
Pediatric Pulmonology
|
August 19, 2010
Pulmonary outcome prediction (POP) tools for cystic fibrosis patients
Donald R VanDevanter, Jeffrey S Wagener, David J Pasta, et al.
Pediatric Pulmonology
|
September 18, 2010
Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis
Gregory S Sawicki, Lawrence Rasouliyan, Ann H McMullen, et al.
Page
of 17